NFA
EVH icon

Nationwide Fund Advisors’s Evolent Health EVH Stock Holding History

Nationwide Fund Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-105,375
Closed -$1.88M – 675
2017
Q3 		$1.88M Buy
105,375
+13,057
+14% +$269K 0.01% 1472
2017
Q2 		$2.34M Buy
92,318
+28,903
+46% +$695K 0.01% 1358
2017
Q1 		$1.41M Sell
63,415
-5,437
-8% -$104K 0.01% 1567
2016
Q4 		$1.02M Buy
68,852
+10,733
+18% +$211K ﹤0.01% 1768
2016
Q3 		$1.43M Buy
58,119
+48,010
+475% +$1.12M 0.01% 1573
2016
Q2 		$194K Buy
10,109
+789
+8% +$10.8K ﹤0.01% 2625
2016
Q1 		$98K Buy
9,320
+1,192
+15% +$12.3K ﹤0.01% 2825
2015
Q4 		$98K Buy
8,128
+5,224
+180% +$77K ﹤0.01% 2857
2015
Q3 		$46K Buy
+2,904
New +$56.7K ﹤0.01% 3031

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

Nationwide Fund Advisors's EVH Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 105,375 shares — an estimated $1.88M sold.

Nationwide Fund Advisors first reported a position in EVH in Q3 2015 and held it in 9 quarters. The position peaked at $2.34M in Q2 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 105,375 Evolent Health shares in Q4 2017, an estimated $1.88M.
  • Nationwide Fund Advisors first reported a position in Evolent Health in Q3 2015 and held it in 9 quarters.
  • Nationwide Fund Advisors's Evolent Health position peaked at $2.34M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.